Baohuoside I

Catalog No.S3840 Synonyms: Icariside II

For research use only.

Baohuoside I (Icariside II) is a flavonoid isolated from Epimedium koreanum Nakai with anti-inflammatory and anti-cancer activities. It may exert cytotoxic effect via the ROS/MAPK pathway.

Baohuoside I Chemical Structure

CAS No. 113558-15-9

Purity & Quality Control

Choose Selective ROS Inhibitors

Biological Activity

Description Baohuoside I (Icariside II) is a flavonoid isolated from Epimedium koreanum Nakai with anti-inflammatory and anti-cancer activities. It may exert cytotoxic effect via the ROS/MAPK pathway.
In vitro

Baohuoside I accelerates apoptosis through the mitochondrial apoptotic pathway, involving the increment of BAX/Bcl-2 ratio, dissipation of mitochondrial membrane potential, transposition of cytochrome c, caspase 3 and caspase 9 activation, degradation of poly (ADP-ribose) polymerase and the over-production of reactive oxygen species (ROS)[1]. In vitro studies with three leukaemia and three solid tumour cell lines show that Baohuoside I has cytotoxic properties, with IC50 values of between 2.8 and 7.5 μg/ml[2].

In vivo Baohuoside I is both anti-inflammatory and immunosuppressive, but unlike the cytotoxic and anti-rejection drugs it suppresses only B-cell (antibody) and not T-cell responses. Baohuoside I may have a role in therapy of those autoimmune diseases[2].

Protocol (from reference)

Cell Research:[1]
  • Cell lines: A549 cell
  • Concentrations: 6.25, 12.5, and 25 μM
  • Incubation Time: 24 h
  • Method: Cells (1×106 cells/ml) are exposed to Baohuoside I (6.25, 12.5, and 25 μM) for 24 h, washed with PBS, and then harvested with trypsin EDTA, counted, fixed with 75% ethanol and stored at 4℃ prior to DNA content analyses. Samples are resuspended in 1.0 ml hypotonic propidium iodide (PI)-solution (50 mg/ml PI, 0.1% sodium citrate, 0.1% Triton X-100, 0.1 mg/ml ribonuclease A) and incubated in the dark for 1 h. PI-stained samples are analyzed with a flow cytometer.
  • (Only for Reference)
Animal Research:[2]
  • Animal Models: Inbred female C57/BL/6J mice
  • Dosages: 20, 40, 60 mg/kg
  • Administration: i.p.
  • (Only for Reference)

Solubility (25°C)

In vitro

DMSO 100 mg/mL
(194.35 mM)


* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 514.52
Formula

C27H30O10

CAS No. 113558-15-9
Storage 3 years -20°C powder
2 years -80°C in solvent
Smiles CC1C(C(C(C(O1)OC2=C(OC3=C(C(=CC(=C3C2=O)O)O)CC=C(C)C)C4=CC=C(C=C4)OC)O)O)O

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Interventions Conditions Sponsor/Collaborators Start Date Phases
NCT02931305 Unknown status Drug: Epimedium Prenylflavonoids Extract|Drug: Placebo Osteoporosis|Cardiovascular Disease National University Hospital Singapore October 2016 Phase 1

(data from https://clinicaltrials.gov, updated on 2022-01-17)

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Baohuoside I | Baohuoside I supplier | purchase Baohuoside I | Baohuoside I cost | Baohuoside I manufacturer | order Baohuoside I | Baohuoside I distributor